Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Evidence for aspirin's chemopreventative properties on colorectal cancer (CRC) is substantial, but its mechanism of action is not well-understood. We combined a proteomic approach with Mendelian randomization (MR) to identify possible new aspirin targets that decrease CRC risk.
Pubmed ID: 33318029
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line S/RG/C2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions